clarithromycin has been researched along with fluconazole in 33 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 7 (21.21) | 18.2507 |
2000's | 9 (27.27) | 29.6817 |
2010's | 16 (48.48) | 24.3611 |
2020's | 1 (3.03) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Chen, X; Lin, X; Skolnik, S; Wang, J | 1 |
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Bharate, SS; Vishwakarma, RA | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Tseng, AL; Walmsley, SL | 1 |
Althaus, C; Becker, K; Schimkat, M; Sundmacher, R | 1 |
Brettle, RP | 1 |
Jordan, MK; Kelly, G; Masur, H; Narang, PK; Piscitelli, SC; Polis, MA | 1 |
Cheng, B | 1 |
Bowersox, J | 1 |
Schouten, JT; Whittemore, S | 1 |
De Bruin, ML; Herings, RM; Hoes, AW; Leufkens, HG; Panneman, MJ | 1 |
Bhaloo, S; Prasad, GV | 1 |
Chang, HT; Jung, S; Schelper, RL; Visvesvara, GS | 1 |
Greenspan, DL; Hooton, TM; Jacobson, M; Slattery, JT; Trapnell, CB; Unadkat, JD; Winter, HR | 2 |
Cameron, DW; Elgadi, M; la Porte, CJ; Sabo, JP | 1 |
Kekulé, AS; Kreft, B; Lübbert, C; Marsch, WC; Oehme, A | 1 |
Elsisi, AE; Hegazy, SK; Mabrouk, MM; Mansour, NO | 1 |
Benne, MS; Greupink, R; Huisman, MT; Russel, FG; Schreurs, M | 1 |
Gianni, C | 1 |
Andersen, SE; Buch, T | 1 |
Daali, Y; Desmeules, JA; Marsousi, N; Rudaz, S | 1 |
Ogawa, SI; Shimizu, M; Yamazaki, H | 1 |
4 review(s) available for clarithromycin and fluconazole
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Rifabutin-associated uveitis.
Topics: Anti-Bacterial Agents; Antifungal Agents; Clarithromycin; Clinical Trials as Topic; Drug Interactions; Fluconazole; Humans; Mycobacterium avium-intracellulare Infection; Rifabutin; Uveitis | 1995 |
Mycobacterium avium intracellulare infection in patients with HIV or AIDS.
Topics: AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antifungal Agents; Azithromycin; Clarithromycin; Clinical Trials as Topic; Fluconazole; Humans; Immunocompromised Host; Mycobacterium avium-intracellulare Infection; Rifabutin | 1997 |
Balamuthia mandrillaris meningoencephalitis in an immunocompetent patient: an unusual clinical course and a favorable outcome.
Topics: Aged; Animals; Brain Neoplasms; Central Nervous System Protozoal Infections; Clarithromycin; Diagnosis, Differential; Drug Therapy, Combination; Epilepsy, Partial, Motor; Female; Fluconazole; Humans; Immunocompetence; Lobosea; Magnetic Resonance Imaging; Meningoencephalitis; New York; Opportunistic Infections; Pentamidine; Soil; Sulfadiazine; Texas | 2004 |
5 trial(s) available for clarithromycin and fluconazole
Article | Year |
---|---|
Effects of fluconazole and clarithromycin on rifabutin and 25-O-desacetylrifabutin pharmacokinetics.
Topics: Adult; Anti-Bacterial Agents; Antibiotics, Antitubercular; Antifungal Agents; Clarithromycin; Drug Interactions; Drug Therapy, Combination; Female; Fluconazole; HIV Infections; Humans; Male; Middle Aged; Rifabutin | 2000 |
The effect of clarithromycin, fluconazole, and rifabutin on sulfamethoxazole hydroxylamine formation in individuals with human immunodeficiency virus infection (AACTG 283).
Topics: Adult; Anti-Infective Agents; Area Under Curve; CD4 Lymphocyte Count; Clarithromycin; Drug Interactions; Female; Fluconazole; HIV Infections; HIV-1; Humans; Male; Middle Aged; Rifabutin; Sulfamethoxazole; Trimethoprim, Sulfamethoxazole Drug Combination | 2004 |
The effect of clarithromycin, fluconazole, and rifabutin on dapsone hydroxylamine formation in individuals with human immunodeficiency virus infection (AACTG 283).
Topics: Adult; Algorithms; Anti-Bacterial Agents; Antifungal Agents; Area Under Curve; CD4 Lymphocyte Count; Chromatography, High Pressure Liquid; Clarithromycin; Dapsone; Female; Fluconazole; HIV Infections; Humans; Male; Middle Aged; Rifabutin | 2004 |
Interaction studies of tipranavir-ritonavir with clarithromycin, fluconazole, and rifabutin in healthy volunteers.
Topics: Adolescent; Adult; Anti-HIV Agents; Clarithromycin; Drug Interactions; Female; Fluconazole; HIV Protease Inhibitors; Humans; Male; Middle Aged; Pyridines; Pyrones; Rifabutin; Ritonavir; Sulfonamides | 2009 |
Effect of clarithromycin and fluconazole on the pharmacokinetics of montelukast in human volunteers.
Topics: Acetates; Administration, Oral; Adult; Analysis of Variance; Anti-Asthmatic Agents; Anti-Bacterial Agents; Antifungal Agents; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Biotransformation; Chromatography, High Pressure Liquid; Clarithromycin; Cross-Over Studies; Cyclopropanes; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Administration Schedule; Drug Interactions; Egypt; Enzyme Inhibitors; Fluconazole; Half-Life; Humans; Leukotriene Antagonists; Male; Membrane Transport Modulators; Membrane Transport Proteins; Metabolic Clearance Rate; Models, Biological; Quinolines; Sulfides | 2012 |
24 other study(ies) available for clarithromycin and fluconazole
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Attenuation of intestinal absorption by major efflux transporters: quantitative tools and strategies using a Caco-2 model.
Topics: Adenosine; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Sub-Family B Member 4; ATP-Binding Cassette Transporters; Biological Transport; Caco-2 Cells; Chromatography, Liquid; Dibenzocycloheptenes; Diketopiperazines; Drug Discovery; Heterocyclic Compounds, 4 or More Rings; Humans; Intestinal Absorption; Mass Spectrometry; Models, Biological; Neoplasm Proteins; Pharmaceutical Preparations; Predictive Value of Tests; Propionates; Quinolines; Substrate Specificity | 2011 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Thermodynamic equilibrium solubility measurements in simulated fluids by 96-well plate method in early drug discovery.
Topics: Drug Discovery; Pharmaceutical Preparations; Solubility; Thermodynamics | 2015 |
Uveitis associated with rifabutin therapy.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Fluconazole; Humans; Rifabutin; Uveitis | 1994 |
Rifabutin-associated anterior uveitis in patients infected with human immunodeficiency virus.
Topics: Acute Disease; Administration, Oral; Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antifungal Agents; Clarithromycin; Drug Therapy, Combination; Female; Fluconazole; Follow-Up Studies; Humans; Male; Middle Aged; Mycobacterium avium-intracellulare Infection; Rifabutin; Uveitis, Anterior; Visual Acuity | 1996 |
Preventing opportunistic infections.
Topics: Acyclovir; AIDS-Related Opportunistic Infections; Clarithromycin; Clindamycin; Clinical Trials as Topic; Clotrimazole; Cytomegalovirus Infections; Dapsone; Fluconazole; Ganciclovir; Humans; Itraconazole; Leucovorin; Mycobacterium avium-intracellulare Infection; Mycoses; Pentamidine; Pneumonia, Pneumocystis; Pyrimethamine; Rifabutin; Toxoplasmosis; Trimethoprim, Sulfamethoxazole Drug Combination; Valacyclovir; Valine | 1995 |
CPCRA researchers present OI studies at Vancouver.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Antitubercular Agents; Candidiasis; Child; Clarithromycin; Clinical Trials as Topic; DNA, Viral; Drug Therapy, Combination; Ethambutol; Female; Fluconazole; Humans; Isoniazid; Molluscum Contagiosum; Molluscum contagiosum virus; Multicenter Studies as Topic; Mycobacterium avium-intracellulare Infection; Ofloxacin; Patient Compliance; Pyrazinamide; Rifampin; Sequence Analysis, DNA; Tuberculosis | 1996 |
Recent development in the treatment and prevention of disseminated Mycobacterium avium complex (MAC).
Topics: AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antibiotics, Antitubercular; Antifungal Agents; Azithromycin; Clarithromycin; Clinical Trials as Topic; Dexamethasone; Drug Interactions; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Fluconazole; Humans; Mycobacterium avium-intracellulare Infection; Rifabutin; Risk Factors; Uveitis | 1996 |
Use of cisapride with contraindicated drugs in The Netherlands.
Topics: Cisapride; Clarithromycin; Contraindications; Databases, Factual; Drug Interactions; Drug Labeling; Drug Prescriptions; Fluconazole; Follow-Up Studies; Humans; Miconazole; Netherlands; Retrospective Studies | 2002 |
Severe reduction in tacrolimus levels with rifampin despite multiple cytochrome P450 inhibitors: a case report.
Topics: Adult; Clarithromycin; Creatinine; Cytochrome P-450 Enzyme Inhibitors; Diltiazem; Drug Interactions; Drug Therapy, Combination; Female; Fluconazole; Humans; Immunosuppressive Agents; Kidney Function Tests; Kidney Transplantation; Rifampin; Tacrolimus | 2003 |
[37-year old patient with fever, diarrhea and lymphadenopathy].
Topics: Adult; AIDS Serodiagnosis; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antifungal Agents; Antiretroviral Therapy, Highly Active; Candidiasis, Oral; Ciprofloxacin; Clarithromycin; Diagnosis, Differential; Diarrhea; Drug Therapy, Combination; Fever of Unknown Origin; Fluconazole; Giardia lamblia; Giardiasis; HIV Seropositivity; HIV-1; Homosexuality, Male; Humans; Immunoblotting; Lymphatic Diseases; Male; Metronidazole; Omeprazole | 2010 |
Semi-mechanistic physiologically-based pharmacokinetic modeling of clinical glibenclamide pharmacokinetics and drug-drug-interactions.
Topics: Animals; Anti-Infective Agents; CHO Cells; Clarithromycin; Computer Simulation; Cricetulus; Cytochrome P-450 Enzyme System; Drug Interactions; Fluconazole; Glyburide; HEK293 Cells; Humans; Hypoglycemic Agents; Models, Biological; Rifampin | 2013 |
Treatment and prevention of paronychia using a new combination of topicals: report of 30 cases.
Topics: Administration, Topical; Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antifungal Agents; Chronic Disease; Clarithromycin; Dermatologic Agents; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluconazole; Follow-Up Studies; Humans; Imidazoles; Male; Middle Aged; Nail Diseases; Occupational Diseases; Paronychia; Polymers; Pyridones; Young Adult | 2015 |
[Combination therapy with fluconazole and other QTc-prolonging drugs increase the QTc interval].
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Anti-Bacterial Agents; Antifungal Agents; Clarithromycin; Combined Modality Therapy; Drug Interactions; Electrocardiography; Fluconazole; Heart Rate; Humans; Long QT Syndrome; Male | 2015 |
Prediction of drug-drug interactions using physiologically-based pharmacokinetic models of CYP450 modulators included in Simcyp software.
Topics: Ciprofloxacin; Clarithromycin; Computer Simulation; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 CYP3A Inhibitors; Cytochrome P-450 Enzyme Inducers; Drug Interactions; Fluconazole; Humans; Itraconazole; Ketoconazole; Models, Biological; Paroxetine; Quinidine; Rifampin; Software | 2018 |
Modelled plasma concentrations of pemafibrate with co-administered typical cytochrome P450 inhibitors clopidogrel, fluconazole or clarithromycin predicted by physiologically based pharmacokinetic modelling in virtual populations.
Topics: Benzoxazoles; Butyrates; Clarithromycin; Clopidogrel; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Fluconazole; Humans; Liver; Pharmaceutical Preparations | 2020 |